Please login or sign up to post and edit reviews.
8 Dividend Stocks You Can't Ignore in 2025
Publisher |
EYL Network
Media Type |
audio
Categories Via RSS |
Business,Β 
Business News,Β 
Careers,Β 
Education,Β 
Entrepreneurship,Β 
Investing,Β 
News
Publication Date |
Oct 26, 2024
Episode Duration |
00:06:40

Welcome back to another insightful episode of Market Mondays! πŸ’Ό In this installment, Rashad Bilal and Ian Dunlap dive deep into eight dividend stocks that should be on your radar as we move through 2025. 🎯

Timestamps:

00:00 - Introduction

00:07 - Chevron: Worth the Investment?

01:04 - Verizon: A Reliable Choice?

01:43 - Pfizer: Potential for Growth?

02:30 - UPS: Long-Term Investment?

02:56 - T. Rowe Price: Underrated Gem?

03:35 - CVS: Past its Peak?

04:52 - Kraft Heinz: To Buy or Not to Buy?

05:51 - Sirius XM: Warren Buffett's Move?

Featured Stocks:

1. *Chevron (CVX)* πŸŒπŸ’§

  • Known for its strong long-term returns, Chevron has had a rocky year but is expected to bounce back. Rashad discusses the price points at which this stock becomes a worthy investment.

2. *Verizon (VZ)* πŸ“Ά

  • A utility-type stock that pays a solid dividend, Rashad and Ian talk about why this company is a buy below $34 and how it fits into a diversified portfolio.

3. *Pfizer (PFE)* πŸ’Š

  • Despite some management issues and the loss of exclusive rights to key drugs, Pfizer still holds promise, especially if you can get it at the right price points: $24, $15.46, or $23.10.

4. *UPS (UPS)* πŸ“¦

  • A great stock for long-term holds, UPS remains a stable investment option, although the sector's competitiveness needs consideration.

5. *T. Rowe Price (TROW)* πŸ“ˆ

  • Known for its decent dividends and being a stalwart in the financial space, Rashad expresses his approval for this stock, especially if it dips to $100 or below.

6. *CVS (CVS)* πŸ₯

  • Once a pandemic darling, CVS is now struggling. It's a potential buy only if it drops to $31. Rashad warns against chasing dividends in underperforming companies like this one.

7. *Kraft Heinz (KHC)* πŸ”

  • A controversial pick, mainly due to concerns about product quality. Rashad and Ian discuss why this may not be the best dividend stock for your portfolio.

8. *Sirius XM (SIRI)* πŸ“»

  • Mystery surrounds Warren Buffett's significant stake in this company. Rashad and Ian debate possible reasons behind this intriguing investment, while also questioning its growth potential.

Key Takeaways:

  • *Price Points Matter:* Whether it's Verizon at $34 or UPS at $124, knowing the right price points can make or break your investment strategy.
  • *Sector Leaders vs. Followers:* Rashad insists that you should aim to invest in sector leaders like Nvidia rather than laggards just for the sake of dividends.
  • *Management Concerns:* Companies like Pfizer show that poor management can severely impact stock value, making due diligence crucial.
  • *Future Uncertainties:* Stocks like CVS and Sirius XM demonstrate the importance of considering future market conditions and competition before investing.

Join us as we dissect why these companies are worth a closer look and how to navigate the complexities of dividend investing in the current market climate. Whether you are a seasoned investor or just starting, Market Mondays has you covered with the insights you need to make informed decisions.

Don't forget to like, share, and subscribe for more weekly market insights! πŸ“ˆπŸ””

Related Videos:

  • *Investing in Tech Stocks for 2023*
  • *Should You Buy Real Estate Now?*
  • *Top 5 Crypto Picks for the Next Bull Run*

#MarketMondays #DividendStocks #Investing #StockMarket #FinancialFreedom #Chevron #Verizon #Pfizer #UPS #TRowePrice #CVS #KraftHeinz #SiriusXM #WarrenBuffett #InvestSmart #StockTips

Tune in to level up your investing game! 🌟

Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review